Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-12

Clinical Trial Update: Triple Therapy With Tegoprazan in H. Pylori Positive Patients_PILOT [Phase 3]

View source ↗

Summary

Phase 3 pilot trial update of triple therapy including tegoprazan in Helicobacter pylori infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tegoprazan (tegoprazan)

Snippet

Sponsor: HK inno.N Corporation | Conditions: Helicobacter Pylori Infection | Phase 3 | Status: COMPLETED